Journal of International College of Dentists

Page: 45-48

Periodontal diseases are chronic inflammatory conditions affecting the tooth-supporting structures and represent a significant global health burden due to their high prevalence, complex etiology, and the need for long-term treatment and maintenance. While conventional periodontal therapy effectively halts disease progression through mechanotherapy and chemotherapeutic approaches, predictable regeneration of the lost periodontal apparatus remains a major clinical challenge. Various graft materials such as autografts, allografts, and xenografts have been employed with varying degrees of clinical success; however, consistent histological evidence of true periodontal regeneration remains elusive.

Recent advances in regenerative medicine have shifted focus toward biologically driven strategies involving signaling molecules, cells, and scaffolds to promote periodontal regeneration. Among these, mesenchymal stem/stromal cell (MSC)–derived exosomes have emerged as a promising cell-free therapeutic modality. Exosomes are nano-sized extracellular vesicles that mediate intercellular communication and possess potent immunomodulatory, anti-inflammatory, angiogenic, and regenerative properties. MSC-derived exosomes have demonstrated the ability to suppress inflammatory responses and enhance tissue repair through the delivery of bioactive molecules.

Preclinical evidence suggests that MSC exosome–based therapies can enhance periodontal ligament cell function and promote periodontal regeneration. Experimental studies using exosome-loaded collagen scaffolds have shown significant improvements in alveolar bone formation, functional periodontal ligament regeneration, and inhibition of epithelial down-growth in animal models. These findings indicate that transient exposure to MSC-derived exosomes may initiate sustained endogenous regenerative processes.

Although clinical application of MSC exosomes in periodontology is still in its early stages, ongoing clinical trials highlight their translational potential. MSC-derived exosomes represent a novel and promising approach for achieving predictable periodontal regeneration and may overcome the limitations associated with conventional grafting and cell-based therapies.